Tenon Medical Inc (TNON)

$0.74845

-0.01

(-1.13%)▲

Market is closed - opens 7 PM, 23 May 2024

Insights on Tenon Medical Inc

  • Decreasing Revenue

    Revenue is down for the last 3 quarters, 944.0K → 719.0K (in $), with an average decrease of 12.7% per quarter

  • Decreasing Net Profit

    Netprofit is down for the last 2 quarters, -3.13M → -3.57M (in $), with an average decrease of 14.1% per quarter

  • Vs BSX

    In the last 1 year, Boston Scientific Corp. has given 41.0% return, outperforming this stock by 136.3%

Performance

  • $0.73
    $0.76
    $0.75
    downward going graph

    2.67%

    Downside

    Day's Volatility :3.57%

    Upside

    0.92%

    downward going graph
  • $0.70
    $14.00
    $0.75
    downward going graph

    6.67%

    Downside

    52 Weeks Volatility :95.0%

    Upside

    94.64%

    downward going graph

Returns

PeriodTenon Medical IncIndex (Russel 2000)
3 Months
-29.91%
0.0%
6 Months
-62.52%
0.0%
1 Year
-95.33%
0.0%
3 Years
-99.66%
-20.1%

Highlights

Market Capitalization
3.0M
Book Value
$0.3
Earnings Per Share (EPS)
-85.9
Wall Street Target Price
3.5
Profit Margin
0.0%
Operating Margin TTM
-388.74%
Return On Assets TTM
-112.76%
Return On Equity TTM
-443.27%
Revenue TTM
2.9M
Revenue Per Share TTM
1.61
Quarterly Revenue Growth YOY
191.70000000000002%
Gross Profit TTM
-641.0K
EBITDA
-15.5M
Diluted Eps TTM
-85.9
Quarterly Earnings Growth YOY
0.0
EPS Estimate Current Year
-2.67
EPS Estimate Next Year
-1.26
EPS Estimate Current Quarter
-1.34
EPS Estimate Next Quarter
-0.83

Analyst Recommendation

Buy
    87%Buy
    12%Hold
    0
    0%Sell
Based on 8 Wall street analysts offering stock ratings for Tenon Medical Inc(by analysts ranked 0 to 5 stars)
Based on 8 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
7
6
6
Hold
1
1
1
Sell
00
00
00

Analyst Forecast

What analysts predicted

Upside of 367.63%

Current $0.75
Target $3.50

Company Financials

FY19Y/Y Change
Revenue
53.6K
-
Net Income
-509.6K
-
Net Profit Margin
-950.0%
-
FY20Y/Y Change
Revenue
43.8K
↓ 18.31%
Net Income
-753.0K
↑ 47.77%
Net Profit Margin
-1.7K%
↓ 768.45%
FY21Y/Y Change
Revenue
159.8K
↑ 264.67%
Net Income
-7.7M
↑ 918.29%
Net Profit Margin
-4.8K%
↓ 3080.03%
FY22Y/Y Change
Revenue
691.0K
↑ 332.42%
Net Income
-19.1M
↑ 149.21%
Net Profit Margin
-2.8K%
↑ 2033.07%
FY23Y/Y Change
Revenue
2.9M
↑ 323.73%
Net Income
-15.6M
↓ 18.46%
Net Profit Margin
-532.14%
↑ 2233.27%
Q4 FY22Q/Q Change
Revenue
277.0K
↑ 33.17%
Net Income
-7.9M
↑ 155.91%
Net Profit Margin
-2.8K%
↓ 1364.72%
Q1 FY23Q/Q Change
Revenue
433.0K
↑ 56.32%
Net Income
-4.8M
↓ 39.43%
Net Profit Margin
-1.1K%
↑ 1742.95%
Q2 FY23Q/Q Change
Revenue
743.0K
↑ 71.59%
Net Income
-4.3M
↓ 10.24%
Net Profit Margin
-576.72%
↑ 525.82%
Q3 FY23Q/Q Change
Revenue
944.0K
↑ 27.05%
Net Income
-3.3M
↓ 22.24%
Net Profit Margin
-352.97%
↑ 223.75%
Q4 FY23Q/Q Change
Revenue
808.0K
↓ 14.41%
Net Income
-3.1M
↓ 5.94%
Net Profit Margin
-387.87%
↓ 34.9%
Q1 FY24Q/Q Change
Revenue
719.0K
↓ 11.01%
Net Income
-3.6M
↑ 14.1%
Net Profit Margin
-497.36%
↓ 109.49%
FY19Y/Y Change
Total Assets
268.5K
-
Total Liabilities
1.9M
-
FY20Y/Y Change
Total Assets
390.9K
↑ 45.61%
Total Liabilities
3.1M
↑ 64.65%
FY21Y/Y Change
Total Assets
9.3M
↑ 2271.85%
Total Liabilities
29.8M
↑ 862.2%
FY22Y/Y Change
Total Assets
11.1M
↑ 19.6%
Total Liabilities
4.8M
↓ 83.78%
FY23Y/Y Change
Total Assets
6.3M
↓ 42.78%
Total Liabilities
5.6M
↑ 15.09%
Q4 FY22Q/Q Change
Total Assets
11.1M
↓ 25.76%
Total Liabilities
4.8M
↑ 143.07%
Q1 FY23Q/Q Change
Total Assets
7.6M
↓ 31.2%
Total Liabilities
5.2M
↑ 6.57%
Q2 FY23Q/Q Change
Total Assets
9.9M
↑ 29.18%
Total Liabilities
9.0M
↑ 73.66%
Q3 FY23Q/Q Change
Total Assets
7.3M
↓ 25.74%
Total Liabilities
4.8M
↓ 46.37%
Q4 FY23Q/Q Change
Total Assets
6.3M
↓ 13.3%
Total Liabilities
5.6M
↑ 15.96%
Q1 FY24Q/Q Change
Total Assets
8.0M
↑ 26.4%
Total Liabilities
4.4M
↓ 21.03%
FY19Y/Y Change
Operating Cash Flow
-235.2K
-
Investing Cash Flow
-4.5M
-
Financing Cash Flow
321.3K
-
FY20Y/Y Change
Operating Cash Flow
-167.4K
↓ 28.84%
Investing Cash Flow
-4.5M
↑ 0.0%
Financing Cash Flow
254.8K
↓ 20.7%
FY21Y/Y Change
Operating Cash Flow
-4.3M
↑ 2464.82%
Investing Cash Flow
-4.5M
↑ 0.0%
Financing Cash Flow
11.5M
↑ 4401.35%
FY22Y/Y Change
Operating Cash Flow
-12.0M
↑ 180.14%
Investing Cash Flow
-2.9M
↓ 35.97%
Financing Cash Flow
14.1M
↑ 23.06%
Q4 FY22Q/Q Change
Operating Cash Flow
-3.4M
↓ 0.82%
Investing Cash Flow
2.3M
↓ 277.6%
Financing Cash Flow
-25.0K
↑ 0.0%

Technicals Summary

Sell

Neutral

Buy

Tenon Medical Inc is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

More on Technical Analysis

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Tenon Medical Inc
Tenon Medical Inc
2.3%
-62.52%
-95.33%
-99.66%
-99.66%
Stryker Corporation
Stryker Corporation
0.86%
12.4%
15.49%
28.53%
77.74%
Boston Scientific Corp.
Boston Scientific Corp.
11.25%
36.51%
40.96%
76.8%
100.56%
Edwards Lifesciences Corp.
Edwards Lifesciences Corp.
3.89%
34.72%
1.32%
-5.35%
56.97%
Abbott Laboratories
Abbott Laboratories
-3.84%
0.25%
-4.89%
-12.22%
35.01%
Medtronic Plc
Medtronic Plc
5.71%
8.68%
-4.84%
-33.51%
-4.04%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Tenon Medical Inc
Tenon Medical Inc
NA
NA
NA
-2.67
-4.43
-1.13
NA
0.3
Stryker Corporation
Stryker Corporation
37.6
37.6
2.92
11.96
0.19
0.07
0.01
50.33
Boston Scientific Corp.
Boston Scientific Corp.
63.33
63.33
1.8
2.33
0.09
0.05
NA
13.56
Edwards Lifesciences Corp.
Edwards Lifesciences Corp.
38.77
38.77
5.19
2.76
0.21
0.12
NA
11.82
Abbott Laboratories
Abbott Laboratories
32.15
32.15
5.99
4.63
0.15
0.06
0.02
22.31
Medtronic Plc
Medtronic Plc
26.83
26.83
1.52
5.2
0.08
0.04
0.03
38.95
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Tenon Medical Inc
Tenon Medical Inc
Buy
$3.0M
-99.66%
NA
0.0%
Stryker Corporation
Stryker Corporation
Buy
$125.6B
77.74%
37.6
16.03%
Boston Scientific Corp.
Boston Scientific Corp.
Buy
$110.8B
100.56%
63.33
12.05%
Edwards Lifesciences Corp.
Edwards Lifesciences Corp.
Buy
$54.4B
56.97%
38.77
23.01%
Abbott Laboratories
Abbott Laboratories
Buy
$179.5B
35.01%
32.15
13.96%
Medtronic Plc
Medtronic Plc
Buy
$112.2B
-4.04%
26.83
13.0%

Institutional Holdings

  • TMD Wealth Management, LLC

    11.51%

  • Spectrum Asset Management Inc

    2.23%

  • Vanguard Group Inc

    0.64%

  • Geode Capital Management, LLC

    0.45%

  • Tower Research Capital LLC

    0.14%

  • Lee Financial Corp

    0.09%

Company Information

Organization
Tenon Medical Inc
Employees
21
CEO
Mr. Richard M. Ferrari
Industry
Miscellaneous

Discover More

FAQs